Glaukos

$85.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.88 (-1.02%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Glaukos and other stocks, options, and ETFs commission-free!

About GKOS

Glaukos Corporation, also called Glaukos, is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO
Thomas William Burns
Employees
653
Headquarters
San Clemente, California
Founded
1998
Market Cap
3.76B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
425.99K
High Today
$86.35
Low Today
$84.84
Open Price
$86.35
Volume
202.69K
52 Week High
$99.00
52 Week Low
$31.50

GKOS Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 5, After Hours

You May Also Like

MOGO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure